Literature DB >> 23716596

The Keap1-Nrf2 system prevents onset of diabetes mellitus.

Akira Uruno1, Yuki Furusawa, Yoko Yagishita, Toshiaki Fukutomi, Hiroyuki Muramatsu, Takaaki Negishi, Akira Sugawara, Thomas W Kensler, Masayuki Yamamoto.   

Abstract

Transcription factor Nrf2 (NF-E2-related factor 2) regulates a broad cytoprotective response to environmental stresses. Keap1 (Kelch-like ECH-associated protein 1) is an adaptor protein for cullin3-based ubiquitin E3 ligase and negatively regulates Nrf2. Whereas the Keap1-Nrf2 system plays important roles in oxidative stress response and metabolism, the roles Nrf2 plays in the prevention of diabetes mellitus remain elusive. Here we show that genetic activation of Nrf2 signaling by Keap1 gene hypomorphic knockdown (Keap1flox/-) markedly suppresses the onset of diabetes. When Keap1flox/- mice were crossed with diabetic db/db mice, blood glucose levels became lower through improvement of both insulin secretion and insulin resistance. Keap1flox/- also prevented high-calorie-diet-induced diabetes. Oral administration of the Nrf2 inducer CDDO-Im {oleanolic acid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl] imidazole} also attenuated diabetes in db/db mice. Nrf2 induction altered antioxidant-, energy consumption-, and gluconeogenesis-related gene expression in metabolic tissues. Thus, the Keap1-Nrf2 system is a critical target for preventing the onset of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23716596      PMCID: PMC3719683          DOI: 10.1128/MCB.00225-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages.

Authors:  T Ishii; K Itoh; S Takahashi; H Sato; T Yanagawa; Y Katoh; S Bannai; M Yamamoto
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

2.  Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness.

Authors:  Michael D Conkright; Ernesto Guzmán; Lawrence Flechner; Andrew I Su; John B Hogenesch; Marc Montminy
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

3.  The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase.

Authors:  Sara B Cullinan; John D Gordan; Jianping Jin; J Wade Harper; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

4.  Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene.

Authors:  Hye-Youn Cho; Anne E Jedlicka; Sekhar P M Reddy; Liu-Yi Zhang; Thomas W Kensler; Steven R Kleeberger
Journal:  Am J Respir Cell Mol Biol       Date:  2002-01       Impact factor: 6.914

5.  The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.

Authors:  M McMahon; K Itoh; M Yamamoto; S A Chanas; C J Henderson; L I McLellan; C R Wolf; C Cavin; J D Hayes
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

6.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.

Authors:  J C Yoon; P Puigserver; G Chen; J Donovan; Z Wu; J Rhee; G Adelmant; J Stafford; C R Kahn; D K Granner; C B Newgard; B M Spiegelman
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

7.  Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation.

Authors:  Nobunao Wakabayashi; Ken Itoh; Junko Wakabayashi; Hozumi Motohashi; Shuhei Noda; Satoru Takahashi; Sumihisa Imakado; Tomoe Kotsuji; Fujio Otsuka; Dennis R Roop; Takanori Harada; James Douglas Engel; Masayuki Yamamoto
Journal:  Nat Genet       Date:  2003-09-28       Impact factor: 38.330

8.  Identification of polymorphisms in the promoter region of the human NRF2 gene.

Authors:  Tae Yamamoto; Keigyou Yoh; Akira Kobayashi; Yukio Ishii; Shigeo Kure; Akio Koyama; Tohru Sakamoto; Kiyohisa Sekizawa; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  2004-08-13       Impact factor: 3.575

Review 9.  Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.

Authors:  Karen T Liby; Michael B Sporn
Journal:  Pharmacol Rev       Date:  2012-09-10       Impact factor: 25.468

10.  Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.

Authors:  Akira Kobayashi; Moon-Il Kang; Hiromi Okawa; Makiko Ohtsuji; Yukari Zenke; Tomoki Chiba; Kazuhiko Igarashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

View more
  124 in total

Review 1.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

2.  Nrf2 represses the onset of type 1 diabetes in non-obese diabetic mice.

Authors:  Yoko Yagishita; Akira Uruno; Dionysios V Chartoumpekis; Thomas W Kensler; Masayuki Yamamoto
Journal:  J Endocrinol       Date:  2019-01-01       Impact factor: 4.286

3.  Coptisine ameliorates renal injury in diabetic rats through the activation of Nrf2 signaling pathway.

Authors:  Jiajia Zhai; Zeping Li; Huifeng Zhang; Louyan Ma; Zhengquan Ma; Yi Zhang; Jian Zou; Mo Li; Li Ma; Xiaomiao Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-16       Impact factor: 3.000

Review 4.  Haeme oxygenase signalling pathway: implications for cardiovascular disease.

Authors:  Laura E Fredenburgh; Allison A Merz; Susan Cheng
Journal:  Eur Heart J       Date:  2015-03-31       Impact factor: 29.983

5.  Recombinant FGF21 Protects Against Blood-Brain Barrier Leakage Through Nrf2 Upregulation in Type 2 Diabetes Mice.

Authors:  Zhanyang Yu; Li Lin; Yinghua Jiang; Ian Chin; Xiaojie Wang; Xiaokun Li; Eng H Lo; Xiaoying Wang
Journal:  Mol Neurobiol       Date:  2018-07-19       Impact factor: 5.590

6.  Nuclear factor E2-related factor 2 knockdown enhances glucose uptake and alters glucose metabolism in AML12 hepatocytes.

Authors:  Xiaoyang Yuan; Huijing Huang; Yi Huang; Jinli Wang; Jinhua Yan; Ling Ding; Cuntai Zhang; Le Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

7.  Inhibitor of differentiation proteins protect against oxidative stress by regulating the antioxidant-mitochondrial response in mouse beta cells.

Authors:  Mohammed Bensellam; Magdalene K Montgomery; Jude Luzuriaga; Jeng Yie Chan; D Ross Laybutt
Journal:  Diabetologia       Date:  2015-01-31       Impact factor: 10.122

8.  Adipose-specific ablation of Nrf2 transiently delayed high-fat diet-induced obesity by altering glucose, lipid and energy metabolism of male mice.

Authors:  Le Zhang; Kalavathi Dasuri; Sun-Ok Fernandez-Kim; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

9.  Targeting Nrf2 by dihydro-CDDO-trifluoroethyl amide enhances autophagic clearance and viability of β-cells in a setting of oxidative stress.

Authors:  Wenjuan Li; Weiwei Wu; Haibo Song; Fang Wang; Huanjie Li; Li Chen; Yimu Lai; Joseph S Janicki; Keith W Ward; Colin J Meyer; Xing Li Wang; Dongqi Tang; Taixing Cui
Journal:  FEBS Lett       Date:  2014-05-08       Impact factor: 4.124

10.  Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1.

Authors:  Toshiaki Fukutomi; Kenji Takagi; Tsunehiro Mizushima; Noriaki Ohuchi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2013-12-23       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.